Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP) | MicrobiomeTrials← Back to trialsNCT07756840
Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-09-15Est. Completion: 2029-07-01
Enrollment target: 50 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Respiratory Tract DiseasesNeoplasmsNeoplasms by Histologic TypeNeoplasms, Glandular and EpithelialNeoplasms, Squamous CellTumor Virus InfectionsInfectionsVirus DiseasesDNA Virus InfectionsPathologic ProcessesDisease AttributesRecurrencePapillomaRespiratory Tract InfectionsPapillomavirus Infections
Background:
Recurrent respiratory papillomatosis (RRP) is a rare disease that causes wart-like growths in the airways. …
Bethesda, United StatesEst. completion Jul 31, 2027
Recurrent Respiratory Papillomatosis
The purpose of this study is to evaluate the safety and immunogenicity of autologous DC vaccine in recurrent respiratory…
Scottsdale, United StatesEst. completion Jun 2027